Aspirin, Heparin and Miscarriage

Phase 4

• Conditions: Pregnancy; Miscarriage
• Interventions: Drug: Aspirin; Drug: Heparin

• Registration Number: NCT01917799
• Lead Sponsor: University of Khartoum

Brief Summary

Efficacy of low dose aspirin (LDA) versus LDA plus low-molecular-weight-heparin (LMWH) in patients with a history of recurrent miscarriages.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-01
• Study First Submitted: 2013-07-31
• Status Verified: 2013-08
• Study First Submitted QC: 2013-08-06
• Last Update Submitted: 2013-08-06
• Study First Posted: 2013-08-07
• Last Update Posted: 2013-08-07
• Primary Completion: 2013-11
• Study Completion: 2013-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 150

Inclusion Criteria

• Pregnant women
• History of 2 or more of miscarriage

Read More

Exclusion Criteria

• Twins

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Aspirin	Aspirin	75mg tab of aspirin once daily
Aspirin + heparin	Aspirin	75mg tab of aspirin once daily + 0.4 mL/day of injection of low molecular weight heparin
Aspirin + heparin	Heparin	75mg tab of aspirin once daily + 0.4 mL/day of injection of low molecular weight heparin

Primary Outcome Measures

Name	Time	Method
Number of miscarriages	3 months	To compare number of miscarriages between the two groups

Trial Locations

Locations (1)

Misurata Teaching Hospital; 🇱🇾 Misurata, Libyan Arab Jamahiriya